At A Glance
- IGF-1 LR3 is a modified version of IGF-1, a signal involved in cell growth. Its main point of difference is how it interacts with the binding proteins that normally hold and regulate IGF-1.
- LR3 interacts less strongly with IGF-binding proteins, changing how much analogue can reach receptors in some models.
- Their structures differ even though IGF-1-receptor activity connects them.
What Is IGF-1 LR3?
IGF-1 LR3 is a modified version of IGF-1, a signal involved in cell growth. Its main point of difference is how it interacts with the binding proteins that normally hold and regulate IGF-1.
LR3 has an extension and an amino-acid substitution that reduce its affinity for several IGF-binding proteins. That can leave more of the signal available to reach receptors in some experimental settings. Availability, rather than a simple “stronger” label, is the useful idea here.
Why Do Researchers Use The LR3 Version?
It helps explore how binding proteins shape a cell’s response. Change the proteins surrounding a cell and the same signal can behave differently. LR3 gives scientists a way to examine that often-overlooked part of growth biology.
How Does LR3 Compare With IGF-1 DES?
LR3 is extended and modified; DES has its first three amino acids removed. Both change binding-protein interactions, but by different designs. Native IGF-1 is the reference point. The surrounding serum and binding proteins help explain why comparisons can differ between studies.
A Closer Look At IGF-1 LR3
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Laboratory research | Availability of the growth signal | LR3 interacts less strongly with IGF-binding proteins, changing how much analogue can reach receptors in some models. | The linked comparison is animal work. |
| Comparison | LR3, DES, and native IGF-1 | Their structures differ even though IGF-1-receptor activity connects them. | Clinical findings for mecasermin concern a different, regulated IGF-1 product. |
Common Questions About IGF-1 LR3
What is IGF-1 LR3?+
IGF-1 LR3 is a modified version of IGF-1, a signal involved in cell growth. Its main point of difference is how it interacts with the binding proteins that normally hold and regulate IGF-1.
Why do researchers use the LR3 version?+
It helps explore how binding proteins shape a cell’s response. Change the proteins surrounding a cell and the same signal can behave differently. LR3 gives scientists a way to examine that often-overlooked part of growth biology.
How does LR3 compare with IGF-1 DES?+
LR3 is extended and modified; DES has its first three amino acids removed. Both change binding-protein interactions, but by different designs. Native IGF-1 is the reference point. The surrounding serum and binding proteins help explain why comparisons can differ between studies.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- Long R3 insulin-like growth factor-I infusion and IGF-binding-protein-dependent responsesPubMed-indexed primary study · 1995
Primary animal study comparing LR3IGF-I with native IGFs. Its binding-protein context and model must remain attached to the reported response.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For IGF-1 LR3 context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote For IGF-1 LR3
This compound is not currently stocked. Add it to your five-choice catalogue ballot.